Skip to content

Comparison of Inflammatory Markers in Peyronie's Disease: C-Reactive Protein, Neutrophil-to-Lymphocyte Ratio, and Inflammatory Burden Index.

Oct 2026 · The French journal of urology · Vol 37, pp. 103262 · 0 citations
Medicine

TL;DR

CRP and IBI were elevated in Peyronie's disease and were higher with shorter recorded curvature duration, but symptom-based analyses did not support either marker as a reliable indicator of clinically active disease.

Abstract

INTRODUCTION To compare C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and inflammatory burden index (IBI) in Peyronie's disease (PD), assess their discriminatory performance and associations with recorded curvature duration and penile pain, and determine whether IBI provides additional information beyond CRP.

Materials And Methods

This retrospective case-control study included 104 patients with PD and 127 controls. IBI was calculated as CRP × NLR. Group comparisons, ROC analyses with paired DeLong tests, and multivariable logistic regression were performed. PD-only analyses evaluated recorded curvature duration (≤12 vs >12 months) and pain-related associations.

Results

CRP and IBI were higher in patients with PD than controls [2.26 vs 0.50 mg/L and 3.74 vs 0.91, respectively; both p<0.001], whereas NLR did not differ (p=0.587). AUCs were 0.781 for CRP, 0.765 for IBI, and 0.521 for NLR; CRP and IBI showed similar discrimination (DeLong p=0.163). CRP and IBI remained independently associated with PD, while adding NLR to CRP did not improve model fit. Both were higher with shorter curvature duration. Pain-related analyses were inconsistent: CRP lost significance after adjustment, IBI was not associated with pain, and NLR showed an inverse association. IBI was not correlated with curvature degree or plaque dimensions.

Conclusion

CRP and IBI were elevated in PD and were higher with shorter recorded curvature duration. However, symptom-based analyses did not support either marker as a reliable indicator of clinically active disease. IBI did not outperform CRP or provide incremental information beyond it, and IBI did not reflect anatomical disease severity.

View source

Similar papers

Open access Nov 2026

Assessment of C-Reactive Protein/Albumin Ratio and Other Inflammatory Markers in Rosacea: A Case–Control Study

Background: Although rosacea is a persistent inflammatory illness, a specific parameter capable of demonstrating its severity has not been established. This study examined C-reactive protein (CRP) and CRP/ albumin ratio (CAR) levels in rosacea patients, comparing them with those in healthy control groups and investigat...

A. O. Soğuksu, Erdal Pala · 0 citations
Open access Oct 2026

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Patients with Pterygium: A Retrospective CaseControl Study

Background/Objectives: Inflammation is implicated in pterygium, but whether routine blood-count indices are associated with pterygium independently of age is unclear. We evaluated the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in systemically healthy patients with pterygium and systemic...

Ahmet Duhan Ozbay, Adem Turk, Gokhan Ozgur · 0 citations
Open access Sep 2026

Aggregate Index of Systemic Inflammation in Behçet’s Disease: Association with Disease Activity

Objective: The aggregate index of systemic inflammation (AISI) is a recently introduced composite inflammatory marker derived from neutrophil, monocyte, lymphocyte, and platelet counts. This study aimed to evaluate AISI values in patients with Behçet’s disease (BD), compare them with healthy controls, and investigate t...

Zeynep Kaya, S. Ösken · 0 citations
Open access Oct 2026

Levels of C-Reactive Protein and D-Dimers in Chronic Urticaria as Markers of Severity

Objective: To assess C-reactive protein (CRP) and D-dimers as possible indicators of disease severity in individuals with chronic spontaneous urticaria (CSU), and to investigate additional inflammatory, allergic, and coagulation factors. Study Design: Cross sectional analytical study. Place and Duration of Study: Derma...

Z. Khan, Arfan-Ul-Bari, H. Qureshi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.